31 F
Indianapolis
Thursday, March 28, 2024

TAG

pdl

Lilly licenses PDL type 1 diabetes drug candidate

PDL BioPharma Inc. said Monday that Eli Lilly & Co. is licensing its drug candidate teplizumab, an experimental treatment for newly diagnosed type 1...
- Advertisement -

Subscribe to our newsletter

To be updated with all the latest local news.

Stay connected

1FansLike
1FollowersFollow
1FollowersFollow
1SubscribersSubscribe

Latest news

- Advertisement -
EspaƱol + Translate Ā»
Skip to content